An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells
(1) Padua University Surgical and Gastroenterological Sciences, Padua, 35128, Italy;(2) Gene Therapy Unit, Center for Applied Medical Research, Pio XII, 55, Pamplona, 31008, Spain